Episode 322 ASCO24: The role of ctDNA in the TheraP trial (LuPSMA vs cabazitaxel in CRPC)

The Uromigos - A podcast by The Uromigos

Try Bookbeat 60! days for free, click here

Enjoy a whole world of audiobooks and e-books, everything from new releases to the classics

Alex Wyatt describes the predictive resistance of ctDNA fraction at baseline in predicting outcome.